Skip to main content
. 2018 Nov 19;58(6):817–820. doi: 10.2169/internalmedicine.1870-18

Figure 1.

Figure 1.

Clinical management of a patient with metastatic anaplastic lymphoma kinase (ALK)-rearranged non-small-cell lung cancer (NSCLC). The figure shows several lines of therapy received by the patient for metastatic ALK-rearranged NSCLC as well as the duration of each treatment. Computed tomography during the incipient stage revealed one nodular lesion each in both the left and right lobes (arrows). The metastatic liver lesions (arrowheads) were drastically reduced by ceritinib administration.